Clinical Trials

Meningioma

NCT05278208 2026-04-13

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1/2 Recruiting

65 enrolled

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT02523014 2026-04-07

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

124 enrolled

Meningioma

NCT06275919 2026-03-27

MIRAGE

104 enrolled

Meningioma

NCT07413796 2026-03-27

NEURO-SUTURE

382 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

30 enrolled

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

72 enrolled

Meningioma

NCT03971461 2026-03-11

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

32 enrolled

Meningioma

NCT06104930 2026-03-10

MOLI

60 enrolled

Phase EARLY_PHASE1 Active not recruiting

Meningioma

NCT02933736 2026-03-06

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

48 enrolled

Glioblastoma, Meningioma

NCT05425004 2026-03-05

Cabozantinib for Patients With Recurrent or Progressive Meningioma

24 enrolled

Phase 2 Not yet recruiting

Meningioma, Central Nervous System Neoplasms

NCT04298541 2026-02-27

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

6 enrolled

Meningioma

NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 4 Recruiting

20 enrolled

Phase 2 Not yet recruiting

Meningioma

NCT07428616 2026-02-24

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

100 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Meningioma

NCT07428213 2026-02-23

PIVIM

40 enrolled

Meningioma

NCT06878469 2026-02-19

SIMPLIF-AI

200 enrolled

Brain Neoplasms, Meningioma

NCT04278118 2026-02-17

HiPPI

70 enrolled

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT05957679 2026-02-12

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

20 enrolled

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Meningioma, Neurofibroma, Spinal Cord Neoplasms

NCT06955208 2026-02-12

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

300 enrolled

Tissue Adhesions, Meningioma

NCT06132685 2026-02-10

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

200 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Meningioma

NCT07398066 2026-02-09

DEX-NEURO

60 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

NCT07398170 2026-02-09

BIOLIMEN-1

15 enrolled

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

30 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT06650163 2026-02-05

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Phase 1 Recruiting

20 enrolled

Brain Neoplasms, Glioma, Meningioma

NCT03279692 2026-01-29

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

26 enrolled 14 charts

Meningioma

NCT02648997 2026-01-26

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

40 enrolled 14 charts

Meningioma

NCT06012929 2026-01-26

A Study of ONC201 for Refractory Meningioma

Phase 2 Withdrawn

Meningioma

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Phase 1 Suspended

24 enrolled

Meningioma

NCT06752096 2026-01-16

Robot-Assisted Neurovascular Intervention

10 enrolled

Ischemic Stroke, Meningioma, Stroke

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Recruiting

163 enrolled

Meningioma

NCT04374305 2026-01-12

INTUITT-NF2

100 enrolled

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

18 enrolled

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

30 enrolled

Meningioma

NCT04541082 2025-12-18

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Phase 1 Recruiting

102 enrolled

CNSSarcoma

Typical Teratoid Rhabdoid Tumor, Astrocytoma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Gliosarcoma

NCT04082520 2025-12-11

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

41 enrolled

Phase EARLY_PHASE1 Terminated

Meningioma

NCT02282917 2025-12-05

Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma

7 enrolled 19 charts

Meningioma, Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT04081701 2025-11-21

DOMINO-START

Phase 4 Recruiting

200 enrolled

Medulloblastoma, Meningioma, Paraganglioma, Pituitary Neoplasms, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory, Hemangioblastoma

NCT06930846 2025-11-21

HOBSCOTCH-CA

125 enrolled

CNSGastrointestinalGenitourinarySarcoma

Caregiver Burden, Brain Neoplasms, Memory Disorders, Meningioma, Oligodendroglioma, Cognitive Dysfunction

NCT02162732 2025-11-03

Molecular-Guided Therapy for Childhood Cancer

Phase NA Completed

186 enrolled 12 charts

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

40 enrolled

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT06439420 2025-10-01

CBT-I in PBT

Phase 2 Completed

70 enrolled

CNSLymphoid

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT06326190 2025-09-16

LUMEN-1

136 enrolled

Meningioma

NCT06831461 2025-09-16

PRIDE

156 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Brain Neoplasms, Meningioma, Pituitary Neoplasms

NCT07172178 2025-09-15

γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma

12 enrolled

Meningioma

NCT04239092 2025-07-17

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Phase 1 Terminated

40 enrolled